Literature DB >> 29609968

Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.

Diego Garcia1, Alexandra Porras2, Alejadro Rico Mendoza3, Nelson Alvis4, Maria Cristina Navas5, Fernando De La Hoz6, Marlen De Neira7, Elkin Osorio1, José Fernando Valderrama1.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) infection is highly endemic in the Colombian Amazon basin. In Colombia, the universal hepatitis B vaccination in that area has been active since 1993. The program targets children aged under five years. Newborns receive at least three doses, and in 2001, HBV vaccine birth dose was included. This study aimed to evaluate the advances on HBV control in the Colombian Amazon.
METHODS: A population-based cross-sectional study was conducted in children less than 11 years old in rural areas of the Colombian Amazon, in order to assess the current levels of HBV prevalence and evaluate the effectiveness of HBV vaccination. Participants were selected from villages scattered along the Amazon, Putumayo and Loretoyaco Rivers. Blood samples were taken from children. All the samples were examined for surface antigen (HBsAg) and IgG antibodies against core antigen (AntiHBc) of HBV. Data on HBV vaccination status and other risk factors were also collected.
RESULTS: Blood samples from 1275 children were included in the study. The positivity for IgG AntiHBC and HBsAg was 3.8% and 0.5%, respectively. It was observed that receiving a dose of HBV vaccine within 48 h after birth decreased the risk of HBV infection and carriage by 95%. Being born to an AntiHBc positive mother increased 8 times the risk of HBV infection (OR = 7.8 CI 95% 3.3-10.2) and 7 times the risk of HBsAg carriage (OR = 6.6 CI 95% 2.1-10.1).
CONCLUSION: The prevalence of HBV infection and HBsAg carriage continues to decrease among children living in the Colombian Amazon. The high protective effectiveness of an HBV birth does suggest that perinatal transmission is important in endemic areas of Latin America, an aspect that has not been fully studied in the region.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Colombia; Effectiveness of HBV birth dose; Hepatitis B; Prevalence

Mesh:

Substances:

Year:  2018        PMID: 29609968     DOI: 10.1016/j.vaccine.2017.11.004

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Prevalence of Chronic Hepatitis B Virus Infection among Children in Haiti, 2017.

Authors:  Lana Childs; Paul Adrien; Anna A Minta; Jeannot François; Nadia Phaïmyr Jn Charles; Valery Blot; Gloria Rey-Benito; Jodi L Vanden Eng; Rania A Tohme
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

Review 2.  Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities.

Authors:  Jodie Dionne-Odom; Basile Njei; Alan T N Tita
Journal:  Clin Ther       Date:  2018-07-05       Impact factor: 3.393

3.  Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis.

Authors:  Ali Mohammad Mokhtari; Mohsen Barouni; Mohsen Moghadami; Jafar Hassanzadeh; Rebecca Susan Dewey; Alireza Mirahmadizadeh
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

4.  Association of Routine Hepatitis B Vaccination and Other Effective Factors with Hepatitis B Virus Infection: 25 Years Since the Introduction of National Hepatitis B Vaccination in Iran.

Authors:  Ali Mohammad Mokhtari; Mohsen Moghadami; Mozhgan Seif; Alireza Mirahmadizadeh
Journal:  Iran J Med Sci       Date:  2021-03

Review 5.  Insights into induction of the immune response by the hepatitis B vaccine.

Authors:  Federico Alejandro Di Lello; Alfredo Pedro Martínez; Diego Martín Flichman
Journal:  World J Gastroenterol       Date:  2022-08-21       Impact factor: 5.374

6.  The effectiveness of the national hepatitis B vaccination program 25 years after its introduction in Iran: a historical cohort study.

Authors:  Mohsen Moghadami; Nazanin Dadashpour; Ali Mohammad Mokhtari; Mostafa Ebrahimi; Alireza Mirahmadizadeh
Journal:  Braz J Infect Dis       Date:  2019-11-01       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.